57 results
8-K
EX-99.2
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
) with moderate-to-severe immune compromise; our plans and strategy related to the launch and commercialization of PEMGARDA, including expectations regarding … , including important safety information and boxed warning. 4
INVIVYD CONTINUES TO RAPIDLY EXECUTE TO PLAN Our commercial strategy is built around 3
8-K
EX-99.1
IVVD
Invivyd Inc
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
to COVID-19 disease in the U.S. This EUA milestone represents strategic proof-of-concept for our company and platform, affirming the unique strategy we
8-K
EX-99.3
IVVD
Invivyd Inc
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
and marketing strategy, and our ability to secure third-party coverage and reimbursement for PEMGARDA, and the timing thereof; our plans to share launch
8-K
EX-99.1
0yjebxnpggkjzpj6zt
8 Jan 24
Other Events
7:12am
8-K
EX-99.1
r48dtly
3 Jan 24
Other Events
7:06am
424B5
g7168kn
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.2
7fkv5a 0bpb
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
EX-99.1
alg l6cok
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
EX-99.1
lzim3d wvole
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
8-K
8n2zwqwvhd6rtv 6v
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
8-K
EX-99.1
k0tpyyd7x0uv
29 Jun 23
Other Events
7:08am
8-K
EX-99.1
mvn owbhcvsx
11 May 23
Invivyd Reports First Quarter 2023 Financial Results and Business Highlights
4:08pm
DEF 14A
jsq4hh d1
10 Apr 23
Definitive proxy
4:07pm